Effects of ketamine in treatment-refractory obsessive-compulsive disorder (Q36887096)

16 August 2017

Effects of ketamine in treatment-refractory obsessive-compulsive disorder (English)

1 reference

obsessive-compulsive disorder

16 August 2017

1 reference

Zubin Bhagwagar

8

0 references

Christopher Pittenger

object named as

Christopher Pittenger

10

0 references

John Krystal

7

object named as

John H Krystal

1 reference

16 August 2017

6

James F Leckman

1 reference

16 August 2017

9

Gerard Sanacora

1 reference

Angeli Landeros-Weisenberger

16 August 2017

3

object named as

Angeli Landeros-Weisenberger

1 reference

16 August 2017

Michael H Bloch

1

1 reference

16 August 2017

Suzanne Wasylink

2

1 reference

16 August 2017

Kaitlyn E Panza

4

1 reference

16 August 2017

Eileen Billingslea

5

1 reference

16 August 2017

language of work or name

English

0 references

publication date

10 July 2012

1 reference

16 August 2017

Biological Psychiatry

1 reference

16 August 2017

72

1 reference

16 August 2017

11

1 reference

16 August 2017

964-970

1 reference

Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Signaling pathways underlying the rapid antidepressant actions of ketamine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

A single-blinded case-control study of memantine in severe obsessive-compulsive disorder

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Antidepressant effects of ketamine in depressed patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Rating depressive patients.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Development of a Rating Scale for Primary Depressive Illness

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Treatment of depressive and obsessive-compulsive symptoms in OCD by imipramine and behaviour therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Bupropion for patients with obsessive-compulsive disorder: an open-label, fixed-dose study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Tryptophan depletion in obsessive-compulsive patients

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

The Yale-Brown Obsessive Compulsive Scale. II. Validity

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

A family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder in 378 families

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Lack of effects on core obsessive-compulsive symptoms of tryptophan depletion during symptom provocation in remitted obsessive-compulsive disorder patients

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Glutamatergic dysfunction in OCD.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Obsessive compulsive disorder: comorbid conditions.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Association Testing of the Positional and Functional Candidate Gene SLC1A1/EAAC1 in Early-Onset Obsessive-compulsive Disorder

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3667652

Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine

4 December 2018

1 reference

12 December 2020

Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline

1 reference

12 December 2020

Effects of imipramine on depression and obsessive-compulsive symptoms

1 reference

12 December 2020

Placebo-controlled trial of fluoxetine and phenelzine for obsessive- compulsive disorder

1 reference

12 December 2020

Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)

1 reference

12 December 2020

10.1016/J.BIOPSYCH.2012.05.028

Identifiers

DOI

1 reference

release_d27euh6yabdhlbsntqbihikxta

16 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d27euh6yabdhlbsntqbihikxta

24 November 2022

mapped directly with Wikidata item

1 reference

16 August 2017

PubMed publication ID

22784486

1 reference